Fund shareholders of GH RESEARCH PLC
ISIN IE000GID8VI0 · Ireland · LEI 875500HKJS7QQG6EWH62
- Fund shareholders
- 17
- Of which ETFs
- 7 10 other funds
- Value held
- 85.5M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,813,999 | 43.5M $ | 0.04 % | as of May 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 590,750 | 14.2M $ | 0.05 % | as of May 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 457,300 | 11M $ | 0.04 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 345,892 | 9.3M $ | 0.10 % | as of Jun 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 92,500 | 2.2M $ | 0.04 % | as of May 31, 2026 ↗ |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 71,267 | 1.9M $ | 4.31 % | as of Jun 30, 2026 ↗ |
| iShares MSCI Ireland ETF iShares Trust | 47,400 | 1.1M $ | 1.56 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 40,483 | 971.2K $ | 0.00 % | as of May 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 14,716 | 413.1K $ | 0.89 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 11,163 | 300.1K $ | 0.03 % | as of Jun 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Multi-Asset Fund | 9,007 | 242.1K $ | 0.02 % | as of Jun 30, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 5,998 | 161.2K $ | 0.04 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,325 | 79.8K $ | 0.12 % | as of May 31, 2026 ↗ |
| Parametric International Equity Fund Eaton Vance Mutual Funds Trust | 2,380 | 66.8K $ | 0.03 % | as of Jul 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,294 | 55K $ | 0.07 % | as of May 31, 2026 ↗ |
| First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II | 575 | 15.5K $ | 0.30 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 296 | 8.3K $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.31 % | as of Jun 30, 2026 ↗ |
| iShares MSCI Ireland ETF iShares Trust | 1.56 % | as of May 31, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.89 % | as of Jul 31, 2026 ↗ |
| First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II | 0.30 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.12 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.10 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.07 % | as of May 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 0.05 % | as of May 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 0.04 % | as of May 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 0.04 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 17 | +1 | 3,509,345 | +13.0 % |
| 2026Q2 | 16 | +4 | 3,105,344 | -0.5 % |
| 2026Q1 | 12 | +1 | 3,121,911 | +3.2 % |
| 2025Q4 | 11 | -2 | 3,025,296 | +8.0 % |
| 2025Q3 | 13 | +1 | 2,800,448 | +17.9 % |
| 2025Q2 | 12 | 0 | 2,375,557 | +50.4 % |
| 2025Q1 | 12 | -1 | 1,579,322 | -13.1 % |
| 2024Q4 | 13 | 0 | 1,817,312 | -2.4 % |
| 2024Q3 | 13 | 0 | 1,862,219 | +0.6 % |
| 2024Q2 | 13 | 0 | 1,851,484 | -9.5 % |
| 2024Q1 | 13 | 0 | 2,045,495 | -8.2 % |
| 2023Q4 | 13 | 2,229,292 |
Cite this page
Titelia. "Fund shareholders of GH RESEARCH PLC". https://titelia.com/en/stocks/gh-research-plc-IE000GID8VI0